4.3 Review

Banting Memorial Lecture 2010 Type 2 diabetes as an 'infectious' disease: is this the Black Death of the 21st century?

Journal

DIABETIC MEDICINE
Volume 28, Issue 1, Pages 2-9

Publisher

WILEY
DOI: 10.1111/j.1464-5491.2010.03167.x

Keywords

Black Death; bubonic plague; epidemic; obesity; Type 2 diabetes

Funding

  1. Oxford Radcliffe Hospital
  2. National Institute for Health Research [NF-SI-0508-10272] Funding Source: researchfish

Ask authors/readers for more resources

P>We are currently facing a global pandemic of obesity and Type 2 diabetes. In some settings, the population prevalence of Type 2 diabetes is 50%, and half of those affected will die from diabetes-related complications. Eight centuries ago, an epidemic of bubonic plague swept across Europe, killing at least half of its victims. We here draw comparisons between these two pandemics, proposing close analogies between the 'Black Death' of the 14th century and the modern-day equivalent of Type 2 diabetes. Both diseases can be considered in terms of an aetiological agent, a reservoir, a vector and a predisposing toxic environment; populations can be considered as highly susceptible to the transmissable agents of Type 2 diabetes in the setting of calorie excess, inadequate food labelling, poorly regulated advertising and sedentary lifestyles. As for tackling a pandemic of a contagious microbial pathogen, we believe that breaking the cycle of transmission in the diabetes epidemic must be underpinned by political will and prompt, decisive legislation backed by the medical community. Far from fearing that such measures edge us towards a 'nanny state', we believe individuals should expect a responsible government to safeguard them from the toxic milieu that puts them at risk of obesity and its complications, and that communities and populations have the right to have their health protected.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Immunology

Omicron-Associated Changes in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Symptoms in the United Kingdom

Karina Doris Vihta, Koen B. Pouwels, Tim Ea Peto, Emma Pritchard, Thomas House, Ruth Studley, Emma Rourke, Duncan Cook, Ian Diamond, Derrick Crook, David A. Clifton, Philippa C. Matthews, Nicole Stoesser, David W. Eyre, Ann Sarah Walkerand

Summary: A UK community study found that loss of taste/smell was less common in Omicron BA.1/BA.2 infections compared to Delta severe acute respiratory syndrome coronavirus 2 infections. There were smaller declines in reported shortness of breath, myalgia, and fatigue/weakness, but increases in sore throat, challenging symptom-based testing algorithms.

CLINICAL INFECTIOUS DISEASES (2023)

Article Chemistry, Multidisciplinary

Virus Detection and Identification in Minutes Using Single-Particle Imaging and Deep Learning

Nicolas Shiaelis, Alexander Tometzki, Leon Peto, Andrew McMahon, Christof Hepp, Erica Bickerton, Cyril Favard, Delphine Muriaux, Monique Andersson, Sarah Oakley, Ali Vaughan, Philippa C. Matthews, Nicole Stoesser, Derrick W. Crook, Achillefs N. Kapanidis, Nicole C. Robb

Summary: The increasing frequency and magnitude of viral outbreaks in recent decades, epitomized by the COVID-19 pandemic, has led to an urgent need for rapid and sensitive diagnostic methods. In this study, a methodology for virus detection and identification using a convolutional neural network is presented. The trained neural network was able to differentiate SARS-CoV-2 from negative clinical samples and other respiratory pathogens, as well as closely related strains of influenza and SARS-CoV-2 variants. This approach offers a promising alternative to traditional viral diagnostic and genomic sequencing methods.

ACS NANO (2023)

Article Multidisciplinary Sciences

Systematic review and individual-patient-data meta-analysis of non-invasive fibrosis markers for chronic hepatitis B in Africa

Asgeir Johannessen, Alexander J. Stockdale, Marc Y. R. Henrion, Edith Okeke, Moussa Seydi, Gilles Wandeler, Mark Sonderup, C. Wendy Spearman, Michael Vinikoor, Edford Sinkala, Hailemichael Desalegn, Fatou Fall, Nicholas Riches, Pantong Davwar, Mary Duguru, Tongai Maponga, Jantjie Taljaard, Philippa C. Matthews, Monique Andersson, Souleyman Mboup, Roger Sombie, Yusuke Shimakawa, Maud Lemoine

Summary: This study evaluated the performance of fibrosis biomarkers for the diagnosis of fibrosis and cirrhosis in chronic hepatitis B patients living in sub-Saharan Africa. The aspartate aminotransferase-to-platelet ratio index recommended by the World Health Organization had low sensitivity in detecting cirrhosis. Optimal thresholds were identified for improved diagnosis and treatment recommendations in this setting.

NATURE COMMUNICATIONS (2023)

Article Virology

Polymorphisms predicting phylogeny in hepatitis B virus

Jose Lourenco, Anna L. McNaughton, Caitlin Pley, Uri Obolski, Sunetra Gupta, Philippa C. Matthews

Summary: A machine learning approach was used in this study to identify 10 informative amino acid sites in the HBV genome that can be used to distinguish between different genotypes. These sites were predominantly located in the spacer domain of the polymerase gene, rather than the core protein. These findings improve genotype prediction and provide insights into HBV evolution.

VIRUS EVOLUTION (2023)

Article Biotechnology & Applied Microbiology

An enrichment protocol and analysis pipeline for long read sequencing of the hepatitis B virus transcriptome

Esther Ng, Mihaela-Olivia Dobrica, James M. Harris, Yanxia Wu, Senko Tsukuda, Peter A. C. Wing, Paolo Piazza, Peter Balfe, Philippa C. Matthews, M. Azim Ansari, Jane A. McKeating

Summary: This study used oligonucleotide enrichment and PacBio long read sequencing to identify the repertoire of HBV RNAs. The method allowed for the detection of up to 25% viral sequences and the identification of canonical and non-canonical viral-human transcripts. RNA isolated from de novo HBV infected cells and transfected cells were used to assess the viral transcriptome and annotate truncations and polyadenylation profiles. The enrichment capture and PacBio sequencing method provides an accurate mapping of the HBV transcriptome.

JOURNAL OF GENERAL VIROLOGY (2023)

Article Multidisciplinary Sciences

Protection against SARS-CoV-2 Omicron BA.4/5 variant following booster vaccination or breakthrough infection in the UK

Jia Wei, Philippa Matthews, Nicole Stoesser, John Newton, Ian Diamond, Ruth Studley, Nick Taylor, John Bell, Jeremy Farrar, Jaison Kolenchery, Brian Marsden, Sarah Hoosdally, E. Yvonne Jones, David Stuart, Derrick Crook, Tim E. A. I. Peto, A. Sarah Walker, Koen Pouwels, David Eyre

Summary: This study finds that breakthrough infections provide longer-lasting protection against new Omicron BA.4/5 infections than booster vaccinations. The duration and strength of protection resulting from a booster vaccine dose or breakthrough infection are not well understood.

NATURE COMMUNICATIONS (2023)

Article Multidisciplinary Sciences

COVID-19 vaccination, risk-compensatory behaviours, and contacts in the UK

John Buckell, Joel Jones, Philippa C. Matthews, Sir Ian Diamond, Emma Rourke, Ruth Studley, Duncan Cook, Ann Sarah Walker, Koen B. Pouwels

Summary: The physiological effects of COVID-19 vaccination are well-documented, but the impact on behavior is not well understood. Risk compensation theory suggests that individuals may engage in more risky activities after being vaccinated, offsetting the gains in personal safety. This study found that behavior was not directly related to personal vaccination status, but was influenced by the level of vaccination in the wider population, indicating a potential risk compensation effect.

SCIENTIFIC REPORTS (2023)

Review Biology

The forgotten people: Hepatitis B virus (HBV) infection as a priority for the inclusion health agenda

Emily Martyn, Sarah Eisen, Nicky Longley, Philippa Harris, Julian Surey, James Norman, Michael Brown, Binta Sultan, Tongai G. Maponga, Collins Iwuji, Stuart Flanagan, Indrajit Ghosh, Alistair Story, Philippa C. Matthews

Summary: Hepatitis B virus (HBV) infection is a significant global health threat, causing millions of chronic infections and deaths each year. The impact of HBV disproportionately affects marginalized populations and exacerbates healthcare inequities. The 'inclusion health' agenda seeks to address these disparities and improve HBV diagnosis, treatment, and prevention for excluded populations, contributing to the global goal of eliminating viral hepatitis as a public health threat.

ELIFE (2023)

Article Immunology

Barriers that prevent adults living with HBV infection from participating in clinical research: experience from South Africa

Nombuyiselo Mofokeng, Tongai G. Maponga, Marije van Schalkwyk, Susan Hugo, Molefi Daniel Morobadi, Sabeehah Vawda, Leane Badenhorst, Cloete van Vuuren, Christo van Rensburg, Wolfgang Preiser, Jantjie Taljaard, Su Wang, Veronica Miller, Dan Wu, Joseph D. Tucker, Janet Seeley, Dominique Goedhals, Philippa C. Matthews

Summary: High profile international goals have been set for the elimination of hepatitis B virus (HBV) infection as a public health threat by the year 2030. Developing and expanding equitable, accessible translational HBV research programmes that represent real-world populations are an urgent priority for clinical and academic communities. We present experiences and insights by an expert interdisciplinary group focusing on barriers that impede adults living with HBV infection from participating in clinical studies.

JOURNAL OF VIRUS ERADICATION (2023)

Review Gastroenterology & Hepatology

Enhancing interventions for prevention of mother-to-child- transmission of hepatitis B virus

Philippa C. Matthews, Ponsiano Ocama, Su Wang, Manal El-Sayed, Anna Turkova, Deborah Ford, Judith Torimiro, Ana Cristina Garcia Ferreira, Angelica Espinosa Miranda, Fernando Pio De La Hoz Restrepo, Emmanuel Seremba, Robinson Mbu, Calvin Q. Pan, Homie Razavi, Geoffrey Dusheiko, C. Wendy Spearman, Saeed Hamid

Summary: Prevention of mother-to-child transmission of hepatitis B virus (HBV) infection is crucial for eliminating viral hepatitis, but current guidelines are not consistently followed, especially in high endemicity settings. This article summarizes the evidence for current practice and discusses potential ways to enhance prevention efforts. By reducing health inequities, improving resource allocation, addressing data gaps, advocating for change, and securing consistent investment, significant progress can be made to reduce vertical transmission of HBV.

JHEP REPORTS (2023)

Article Medicine, Research & Experimental

Evolution of long-term vaccine-induced and hybrid immunity in healthcare workers after different COVID-19 vaccine regimens

Shona C. Moore, Barbara Kronsteiner, Stephanie Longet, Sandra Adele, Alexandra S. Deeks, Chang Liu, Wanwisa Dejnirattisai, Laura Silva Reyes, Naomi Meardon, Sian Faustini, Saly Al-Taei, Tom Tipton, Luisa M. Hering, Adrienn Angyal, Rebecca Brown, Alexander R. Nicols, Susan L. Dobson, Piyada Supasa, Aekkachai Tuekprakhon, Andrew Cross, Jessica K. Tyerman, Hailey Hornsby, Irina Grouneva, Megan Plowright, Peijun Zhang, Thomas A. H. Newman, Jeremy M. Nell, Priyanka Abraham, Mohammad Ali, Tom Malone, Isabel Neale, Eloise Phillips, Joseph D. Wilson, Sam M. Murray, Martha Zewdie, Adrian Shields, Emily C. Horner, Lucy H. Booth, Lizzie Stafford, Sagida Bibi, Daniel G. Wootton, Alexander J. Mentzer, Christopher P. Conlon, Katie Jeffery, Philippa C. Matthews, Andrew J. Pollard, Anthony Brown, Sarah L. Rowland-Jones, Juthathip Mongkolsapaya, Rebecca P. Payne, Christina Dold, Teresa Lambe, James E. D. Thaventhiran, Gavin Screaton, Eleanor Barnes, Susan Hopkins, Victoria Hall, Christopher J. A. Ducan, Alex Richter, Miles Carroll, Thushan I. de Silva, Paul Klenerman, Susann Dunachie, Lance Turtle, PITCH Consortium

Summary: In this study, the researchers observed the immune response changes in 684 UK healthcare workers after receiving two doses of BNT162b2 or AZD1222 vaccines during a follow-up period of 6-9 months. The study found that the antibody and memory B cell responses were relatively stable, while the levels of binding and neutralizing antibodies declined. The study also found that individuals with prior infection had stronger and broader T cell responses to the vaccine, especially after receiving the third dose.
Article Medicine, General & Internal

Informing a target product profile for rapid tests to identify HBV-infected pregnant women with high viral loads: a discrete choice experiment with African healthcare workers

Yasir Shitu Isa, Jonathan Sicsic, Henry Njuguna, John Ward, Mohamed Chakroun, Mohamed El-Kassas, Rado Ramanampamonjy, Salim Chalal, Jeanne Perpetue Vincent, Monique Andersson, Hailemichael Desalegn, Fatou Fall, Asgeir Johannessen, Philippa C. Matthews, Gibril Ndow, Edith Okeke, Nicholas Riches, Moussa Seydi, Edford Sinkala, C. Wendy Spearman, Alexander Stockdale, Michael J. Vinikoor, Gilles Wandeler, Roger Sombie, Maud Lemoine, Judith E. Mueller, Yusuke Shimakawa

Summary: To eliminate the transmission of hepatitis B virus (HBV) from mother to child, immunoprophylaxis for infants and antiviral prophylaxis for pregnant women with high viral loads are needed. Rapid diagnostic tests (RDTs) detecting alternative HBV markers may be necessary in low-income and middle-income countries (LMICs) where real-time polymerase chain reaction (RT-PCR) is not accessible or affordable. Through a discrete choice experiment (DCE), healthcare workers (HCWs) in Africa expressed their preferences and trade-offs for different attributes of fictional RDTs.

BMC MEDICINE (2023)

Article Immunology

Hepatitis B Virus Prevalence and Mother-to-Child Transmission Risk in an HIV Early Intervention Cohort in KwaZulu-Natal, South Africa

Jane Millar, Gabriela Z. L. Cromhout, Noxolo Mchunu, Nomonde Bengu, Thumbi Ndung'u, Philip J. Goulder, Philippa C. Matthews, Anna L. McNaughton

Summary: This study investigated the prevalence of hepatitis B virus (HBV) infection in a cohort of HIV-transmitting mother-child pairs in KwaZulu-Natal, South Africa. The study found a high proportion of HBV infection and exposure in the maternal samples, as well as a high risk of mother-to-child transmission (MTCT). The study suggests the need to increase access to birth dose vaccines for infants.

OPEN FORUM INFECTIOUS DISEASES (2023)

Article Infectious Diseases

Patient Biochemistry and Treatment Need in Chronic Hepatitis B Virus Infection Across Three Continents: Retrospective Cross-Sectional Cohort Studies

Iain A. A. Gillespie, Eleanor Barnes, Ian C. K. Wong, Philippa C. C. Matthews, Graham S. S. Cooke, Craig Tipple, Robert C. C. Elston, Yunhao Liu, David A. A. Smith, Tingyan Wang, Jim Davies, Kinga A. A. Varnai, Oliver Freeman, Kenneth K. C. Man, Wallis C. Y. Lau, Ben Glampson, Xing Meng, Eleonora Morais, Sen Liu, Luca Mercuri, Naomi Boxall, Sarah Jenner, Stuart Kendrick, Jane Dong, Dickens Theodore

Summary: This study aimed to characterize patients with chronic HBV infection across different continents and determine their treatment need. The results showed that a considerable proportion of patients who were indicated for treatment were currently untreated, including many patients with fibrosis/cirrhosis.

INFECTIOUS DISEASES AND THERAPY (2023)

Article Public, Environmental & Occupational Health

Hepatitis B in Africa Collaborative Network: cohort profile and analysis of baseline data

Nicholas Riches, Michael Vinikoor, Alice Guingane, Asgeir Johannessen, Maud Lemoine, Philippa Matthews, Edith Okeke, Yusuke Shimakawa, Roger Sombie, Alexander Stockdale, Gilles Wandeler, Monique Andersson, Pantong Davwar, Hailemichael Desalegn, Mary Duguru, Fatou Fall, Tongai Maponga, David Nyam Paul, Moussa Seydi, Edford Sinkala, Jantjie Taljaard, Mark Sonderup, C. Wendy Spearman

Summary: Approximately 80 million people in the WHO Africa Region live with chronic hepatitis B virus (HBV) infection. The natural history of HBV infection in this region is poorly understood and may be different due to various factors. The Hepatitis B in Africa Collaborative Network (HEPSANET) was established in 2022 to improve understanding through data collection and analysis from 13 collaborating HBV cohorts in eight African countries. Baseline data analysis of 4,173 participants with chronic HBV infection revealed important insights.

EPIDEMIOLOGY AND INFECTION (2023)

No Data Available